 |
|
| Venture Capital Asia Pacific (page 2 of 13) |
|
-Carlyle-
Offices: Washington, DC; Charlotte, North Carolina; Bangalore, India;
Barcelona, Spain; Frankfurt, Germany; London, England; Luxemburg; Mexico
City, Mexico; Milan, Italy & Hong Kong, China
The Carlyle Group is one of the world's largest private equity firms, with
more than $89.3 billion under management. With 64 funds across four investment
disciplines (buyouts, growth capital, real estate and leveraged finance),
Launched in 2005 at $1.8 billion, this fund conducts leveraged buyout transactions
in Asia in targeted industries.
Offices: Santa Clara, California
Established in 1999, CCMP Capital Asia is one of the largest and most experienced
buyout firms in Asia with US$2.7 billion in capital commitments under management.
Previously operating and managing J.P. Morgan Partners Asia, the firm's
management team became independent of JPMorgan in 2005 and re-branded itself
as CCMP Capital Asia. They invests in mid-to-large sized market leading
companies in the consumer and industrial sectors across five core markets
– Australia, Greater China, Japan, Korea and Singapore.
Offices: Beijing, China
Ceyuan Ventures is an early stage venture capital firm focused on IT and
emerging growth companies. They emphasize backing great teams, technology
and business innovation. The mission of Ceyuan Ventures is to assist entrepreneurs
in creating and building world-class businesses. Their conviction, network
of relationships and grass roots culture give them the opportunity to discover
the next big idea early.
Offices: Shanghai, China
Chengwei Ventures backs entrepreneurial companies that have scalable business
opportunities in the Chinese economy. They are first and foremost in the
business of backing capable entrepreneurs, and seek to add value to the
creation and building of their businesses. They invest in a variety of industries
including communication software, enterprise software, financial services,
IC design, niche component manufacturing, healthcare and media.
Offices: San Francisco, California; Beijing-Hong Kong-Shanghai, China
& Taipei, Taiwan
ChinaVest was the first independent American venture capital firm to be
established in Greater China and is among the oldest venture firms operating
in the region. Founded in 1983, their singular mission is to provide long
term investment capital and management expertise to growing companies doing
business in or with the economies of Greater China. At the core of their
strategy is the blending of Chinese entrepreneurship with American managerial
and financial discipline—a strategy that has created some extraordinary
companies and rewarded their investors and the entrepreneurs they support
with significant financial returns.
Offices: San Bruno, California & Tokyo, Japan
ChrysCapital manages $1 billion across four funds and aspires to build the
leading investment firm focused on India. Their disciplined investment approach
translates the growth in the Indian economy into superior returns for their
investors. They have developed a strong track record with several successful
realizations. They look to build domain expertise in selected sectors and
then proactively look to identify leading companies. They have in-house
knowledge to act decisively in a broad range of growth industries.-CITI-
Offices: Hong Kong-Shanghai-Beijing, China; Tokyo, Japan & New York,
New York
CITIC Capital Partners, the private equity arm of CITIC Capital, invests
globally in companies which are capitalizing upon the growth and productive
resources of the Chinese economy. They have invested in transactions with
a cumulative enterprise value in excess of US$2.3 billion. Since 1978, CITIC
Group has been investing in and helping to build outstanding businesses
in China in partnership with multi-national corporations.
Offices: London, England; New York, New York; Hong Kong, China & New
Delhi, India
Citi Venture Capital International takes a global view of investing in growth
markets, applying a comparative approach and selecting what it believes
to be the most attractive situations across countries and regions. CVCI,
established in 2001, is a leading private equity investor in growth markets.
In 2005, Citi Venture Capital launched a $1.6 billion fund to make private
equity investments, primarily in companies seeking to profit from the growth
in Greater China, India, Emerging Europe, and to a lesser extent growth
opportunities in other regions including Latin America where CVCI sees clear
potential for growth and value creation.
Offices: San Bruno, California & Tokyo, Japan
CrossBridge Venture Partners is a private equity fund managed by a group
of highly experienced investment professionals who have successfully teamed
together in the past. The primary aim is to earn substantial capital gains
by linking the explosive growth of Silicon Valley technology companies to
the Asian markets. The CrossBridgeAdvantage is a hands-on approach that
offers portfolio companies both timely and strategic access to the world's
second largest market. Management consists of former senior partners at
Silicon Valley Bank, JAFCO, and Techno-Venture in Tokyo who have extensive
experience in venture capital investing in the United States and Asia.
Offices: Boston, Massachusetts & San Francisco, California
CSK Venture Capital is taking advantage of the vast resources of CSK Group.
They have invested in a broad range of IT segments including software, hardware,
telecommunication, and IT services. Over 80% of their investments are in
IT segments. CSK has a worldwide network built through years of global investment
experiences here and abroad. With the networking and experiences, CSK supports
their portfolio companies coming into Japanese market and promote value-enhancing
business relations with selected Japanese companies.
Offices: Hong Kong, China; Tokyo, Japan; Taipei, Taiwan & Singapore
CLSA Capital Partners is the alternative asset management arm of CLSA Asia-Pacific
Markets, Asia's leading independent investment bank and part of one of the
world's top financial institutions. With funds well over US$1 billion, CLSA
Capital Partners offers a diversified and increasing range of investment
vehicles.
Offices: Taipei, Taiwan
Cheng Xin (CX) Venture Capital Group, established in 1990, manages eight
funds (including three biotechnology/life sciences specialty fund) representing
over US$160 million of capital. CX Venture Capital Group makes investment
decisions for its family of funds in both the high technology and biotechnology
industries throughout North America and Asia Pacific regions. High technology
investments primarily include energy, electronics, optoelectronics, communications,
information technology and software. Biotechnology encompasses companies
in pharmaceuticals, medical devices, bioinformatics, healthcare services
and agricultural biotechnology.
Print
(page 3)
Resources
to
top